EXCLUSIVE LICENSE AGREEMENT AMENDMENT #1Exclusive License Agreement • May 13th, 2022 • Blue Water Vaccines Inc. • Pharmaceutical preparations
This Amendment (“Amendment”), effective as of May 11, 2022 (Effective Date), amends that certain Exclusive License Agreement of January 27, 2020 by and between Blue Water Vaccines, Inc. (Company) and St. Jude Children’s Research Hospital, Inc. (St. Jude) (the “License Agreement”).
AMENDMENT 1 TO PROJECT ADDENDUM 2 TO MASTER SERVICES AGREEMENTMaster Services Agreement • May 13th, 2022 • Blue Water Vaccines Inc. • Pharmaceutical preparations
This Amendment 1 (the “Amendment”) is effectively dated as of January 11, 2022 (the “Effective Date”) by and between Blue Water Vaccines, Inc., a Delaware corporation having a principal place of business at 15 East Putnam Avenue, Suite 363, Greenwich, CT 06830 (“Blue Water” or “Client”), and Ology Bioservices, Inc., a Delaware corporation having a principal place of business at 13200 NW Nano Court, Alachua, Florida 32615 (“Ology Bio”). Blue Water and Ology Bio are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
